NanoPhoria Bioscience
PrivateLast Round
Series A
Oct 6, 2025
Total Funding Raised
$121.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NanoPhoria Bioscience is a biopharmaceutical company developing a non-viral drug delivery platform using inorganic nanoparticles to provide treatments for heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoPhoria Bioscience Comparables
Compare NanoPhoria Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AaviGen | 70% | |
| Philip Morris International | 67% | |
| Phoreus Biotechnology, Inc. | 66% |
NanoPhoria Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 6, 2025 | ||||
| Grant | Feb 25, 2025 | ||||
| Seed | May 11, 2022 |
Key People
Founding team and executive leadership
NanoPhoria Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A, Grant |
| XGEN Venture | Series A |
| CDP Venture Capital SGR | Series A |
| Panakès Partners | Series A |
| Sofinnova Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 33% QoQ from 12 to 16 employees.
- Oct 6, 2025
$98M round led by CDP Venture Capital SGR, Sofinnova Partners, and XGEN Venture.
NanoPhoria Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NanoPhoria Bioscience's valuation, stock price, and market status.
Is NanoPhoria Bioscience a public or private company?
NanoPhoria Bioscience is a private company.
What is the current stock price of NanoPhoria Bioscience?
NanoPhoria Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is NanoPhoria Bioscience worth (valuation)?
Valuation information for NanoPhoria Bioscience is not publicly available.
Can I buy NanoPhoria Bioscience stock?
NanoPhoria Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NanoPhoria Bioscience's last funding round?
NanoPhoria Bioscience's most recent funding round was Series A on October 6, 2025.
Who are the main investors in NanoPhoria Bioscience?
Key investors in NanoPhoria Bioscience include XGEN Venture, CDP Venture Capital SGR, Sofinnova Partners.
Will NanoPhoria Bioscience IPO soon?
No public IPO plans have been announced for NanoPhoria Bioscience.
How can I track NanoPhoria Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NanoPhoria Bioscience's secondary market activity and sign up for updates.